Concepedia

Jodi Feser

JF

Statistics

Publications

8

Citations

695

H-Index

8

Active since

2015

Affiliations

Program for Appropriate Technology in Health(Current)

Centers for Disease Control and Prevention

Clinical Research Institute

Icahn School of Medicine at Mount Sinai

University of Maryland, Baltimore

Jodi Feser is an author at Program for Appropriate Technology in Health specializing in vaccination, vaccinology, and immunization.

ORCID

Publications per year

2015–2024

8

Publications

8

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy et al. · Nature Medicine · 2020 · 358 citations

, , +14

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

David I. Bernstein, Jeffrey T. Guptill, Abdollah Naficy et al. · The Lancet Infectious Diseases · 2019 · 140 citations · Full text

, , +17

Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial

John C. Victor, Kristen Lewis, Aldiouma Diallo et al. · The Lancet Global Health · 2016 · 75 citations · Full text

, , +17

Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial

W. Abdullah Brooks, Khalil Zaman, Kristen Lewis et al. · The Lancet Global Health · 2016 · 60 citations · Full text

, , +17

Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh

Justin R. Ortiz, Doli Goswami, Kristen Lewis et al. · Vaccine · 2015 · 21 citations · Full text

, , +17

1–5 of 8